Search Results

Extended-Release, Once-Daily Morphine (Avinza) for the Treatment of Chronic Nonmalignant Pain: Effect on Pain, Depressive Symptoms, and Cognition

Authors: Panjabi, Sumeet S.; Panjabi, Ravi S.; Shepherd, Marvin D.; Lawson, Kenneth A.; Johnsrud, Michael; Barner, Jamie

Source: Pain Medicine, Volume 9, Number 8, November/December 2008 , pp. 985-993(9)

Publisher: Blackwell Publishing

A Study of AVINZA^® (Morphine Sulfate Extended-Release Capsules) for Chronic Moderate-to-Severe Noncancer Pain Conducted Under Real-World Treatment Conditions—The ACCPT Study

Authors: Adams, Edgar H.; Chwiecko, Paul; Ace-Wagoner, Yvonne; Mangefrida, Bethany; Duerden, Mark E.; Perdikis, George C.; Kunkel, Frank A.; Ghalie, Richard

Source: Pain Practice, Volume 6, Number 4, December 2006 , pp. 254-264(11)

Publisher: Blackwell Publishing

Safety updates to US labelling for Avinza

Source: Reactions, Volume 1, Number 1077, 2005-11-12 , pp. 2-2(1)

Publisher: Adis International

Safety updates to US labelling for Avinza

Source: Inpharma, Volume 1, Number 1513, 2005-11-12 , pp. 17-17(1)

Publisher: Adis International

In vitro observations indicate that alcohol compromises the controlled-release characteristics of Kadian [morphine] and Avinza [morphine]

Source: Reactions, Volume 1, Number 1062, 2005-07-30 , pp. 3-3(1)

Publisher: Adis International

In vitro observations indicate that alcohol compromises the controlled-release characteristics of Kadian [morphine] and Avinza [morphine]

Source: Inpharma, Volume 1, Number 1498, 2005-07-30 , pp. 21-21(1)

Publisher: Adis International

Avinza® – 24-h sustained-release oral morphine therapy

Author: Caldwell J.R.

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 2, 1 February 2004 , pp. 469-472(4)

Publisher: Informa Healthcare

Morphine Oral - Elan Corporation: Avinza™

Source: Drugs in R&D, Volume 3, Number 3, 2002 , pp. 208-209(2)

Publisher: Adis International

Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza&unknown;, and a Twice-Daily Controlled-Release Morphine Formulation in Patients with Chronic Moderate-to-Severe Pain

Authors: Portenoy R.K.; Sciberras A.; Eliot L.; Loewen G.; Butler J.; Devane J.

Source: Journal of Pain and Symptom Management, Volume 23, Number 4, April 2002 , pp. 292-300(9)

Publisher: Elsevier

Efficacy and Safety of a Once-Daily Morphine Formulation in Chronic, Moderate-to-Severe Osteoarthritis Pain - Results from a Randomized, Placebo-Controlled, Double-Blind Trial and an Open-Label Extension Trial

Authors: Caldwell J.R.; Rapoport R.J.; Davis J.C.; Offenberg H.L.; Marker H.W.; Roth S.H.; Yuan W.; Eliot L.; Babul N.; Lynch P.M.; for the Avinza&unknown; TRG004-04 Study Group

Source: Journal of Pain and Symptom Management, Volume 23, Number 4, April 2002 , pp. 278-291(14)

Publisher: Elsevier